Arvinas has announced positive biomarker, pharmacokinetic and pharmacodynamic data from two Phase I studies assessing ARV-102, an oral investigational PROTAC degrader of leucine-rich repeat kinase 2 ...

Can you escape your genetic inheritance, and do lifestyle changes actually make a difference? Daniel Cossins set out to understand what the evidence on Alzheimer’s really means for him ...

People who were diagnosed with Parkinson’s disease in their 80s had a higher likelihood of showing evidence of brain buildup of amyloid beta, a protein linked to cognitive decline in Alzheimer’s ...

Dr. William Weiner, a former neurologist at MetroWest Medical Center, was treated by Dr. Krishna Nirmel, whom he mentored.

Arvinas Holding Company ( ($ARVN) ) has issued an update. On October 5, 2025, Arvinas, Inc. announced positive Phase 1 clinical trial results for ...

Myrtelle Inc. ("Myrtelle" or the "Company"), a gene therapy company pioneering transformative treatments for neurodegenerative diseases, today announced that Dr. Michael Muhonen, M.D., Co-Chief ...

Cellestial Health, a pharmaceutical development spin-out from the University of Cambridge, is proving something of a research champion in the field of Parkinson’s disease.The startup has been awarded ...

There are many instances that a child comes to the hospital when it is too late. What seemed like just a mild fever and headache – you thought this was just flu or even dengue could turn out to be ...

Céline Dion made a rare public appearance at a Paul McCartney concert, marking a significant moment amid her ongoing battle with stiff person syndrome.